Serotypes of carriage and invasive isolates of Streptococcus pneumoniae in Brazilian children in the era of pneumococcal vaccines

Clinical Microbiology and Infection

Volumn 12, Issue 1, 2006, Pages 50-55

  Laval, C B ^a   de Andrade, Ana L S S ^a   Pimenta, F C ^a   de Andrade, J G ^a,b   de Oliveira, R M ^a   Silva, S A ^a   de Lima, E C ^a   Di Fabio, J L ^c   Casagrande, S T ^d   Brandileone, M C C ^d  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b Tropical Diseases Hospital   (Brazil)

^c PAN AMERICAN HEALTH ORGANIZATION   (United States)

^d INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

Conjugate vaccine; Invasive disease; Nasopharyngeal carriage; Pneumococci; Serotypes; Streptococcus pneumoniae; Vaccination

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BACTERIUM ISOLATE; BRAZIL; CHILDHOOD DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; LICENCE; MAJOR CLINICAL STUDY; MALE; NOSE SMEAR; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEROTYPE; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; THROAT CULTURE; WINTER;

STREPTOCOCCUS PNEUMONIAE;

EID: 33644849372     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01304.x     Document Type: Article

References (38)

1. Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: The key to pneumococcal disease. Lancet Infect Dis 2004; 4: 144-154.
2. Givon-Lavi N, Fraser D, Porat N, Dagan R. Spread of Streptococcus pneumoniae and antibiotic-resistant S. pneumoniae from day-care center attendees to their younger siblings. J Infect Dis 2002; 186: 1608-1614.
3. de Andrade AL, Pimenta FC, Brandileone MC et al. Genetic relationship between Streptococcus pneumoniae isolates from nasopharyngeal and cerebrospinal fluid of two infants with pneumococcal meningitis. J Clin Microbiol 2003; 41: 3970-3972.
4. Lloyd-Evans N, O'Dempsey TJ, Baldeh I et al. Nasopharyngeal carriage of pneumococci in Gambian children and in their families. Pediatr Infect Dis J 1996; 15: 866-871.
5. Lehmann D, Gratten M, Montgomery J. Susceptibility of pneumococcal carriage isolates to penicillin provides a conservative estimate of susceptibility of invasive pneumococci. Pediatr Infect Dis J 1997; 16: 297-305.
6. Kellner JD, McGeer A, Cetron MS et al. The use of Streptococcus pneumoniae nasopharyngeal isolates from healthy children to predict features of invasive disease. Pediatr Infect Dis J 1998; 17: 279-286.
7. Lee NY, Song JH, Kim S et al. Carriage of antibiotic-resistant pneumococci among Asian children: A multinational surveillance by the Asian Network for Surveillance of Resistant Pathogens (ANSORP). Clin Infect Dis 2001; 32: 1463-1469.
8. Muhlemann K, Matter HC, Tauber MG, Bodmer T. Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infection, Switzerland, 1998-99. J Infect Dis 2003; 187: 589-596.
9. Black S, Shinefield H, Baxter R et al. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J 2004; 23: 485-489.
10. Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, Klugman KP. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 1999; 180: 1171-1176.
11. Dagan R, Givon-Lavi N, Zamir O, Fraser D. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatric Infect Dis J 2003; 22: 532-539.
12. O'Brien KL, Dagan R. The potential indirect effect of conjugate pneumococcal vaccines. Vaccine 2003; 21: 1815-1825.
13. Inostroza J, Trucco O, Prado V, et al. Capsular serotype and antibiotic resistance of Streptococcus pneumoniae isolates in two Chilean cities. Clin Diagn Laboratory Immunol 1998; 5: 176-180.
14. Scott JA, Hall AJ, Hannington A et al. Serotype distribution and prevalence of resistance to benzylpenicillin in three representative populations of Streptococcus pneumoniae isolates from the coast of Kenya. Clin Infect Dis 1998; 27: 1442-1450.
15. Saha SK, Baqui AH, Darmstadt GL et al. Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: Implications for treatment policy and vaccine formulation. J Clin Microbiol 2003; 41: 5582-5587.
16. World Health Organization. Manual for the national surveillance of antimicrobial resistance of S. pneumoniae and H. influenzae: epidemiological and microbiological methods. Programme for the Control of Acute Respiratory Infections. Geneva: WHO, 1994.
17. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 14th informational supplement M100-S14. Wayne, PA: NCCLS, 2004.
18. Brandileone MC, de Andrade AL, Di Fabio JL, Guerra ML, Austrian R. Appropriateness of a pneumococcal conjugate vaccine in Brazil: Potential impact of age and clinical diagnosis, with emphasis on meningitis. J Infect Dis 2003; 187: 1206-1212.
19. Rey LC, Wolf B, Moreira JL, Milatovic D, Verhoef J, Farhat CK. Antimicrobial susceptibility and serotypes of nasopharyngeal Streptococcus pneumoniae in children with pneumonia and in children attending day-care centres in Fortaleza, Brazil. Int J Antimicrob Agents 2002; 20: 86-92.
20. de Andrade AL, de Andrade JG, Martelli CM et al. Effectiveness of Haemophilus influenzae b conjugate vaccine on childhood pneumonia: A case-control study in Brazil. Int J Epidemiol 2004; 33: 173-181.
21. Yu X, Gray B, Chang S, Ward JI, Edwards KM, Nahm MH. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants. J Infect Dis 1999; 180: 1569-1576.
22. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 2003; 187: 1424-1432.
23. Whitney CG, Farley MM, Hadler J et al. Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000; 343: 1917-1924.
24. Coles CL, Kanungo R, Rahmathullah L et al. Pneumococcal nasopharyngeal colonization in young South Indian infants. Pediatr Infect Dis J 2001; 20: 289-295.
25. Tan TQ, Mason EO, Wald ER et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 2002; 110: 1-6.
26. Di Fabio JL, Castaneda E, Agudelo CI et al. Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigia Group, 1993-99. PAHO Sireva-Vigia Study Group. Pan American Health Organization. Pediatr Infect Dis J 2001; 20: 959-967.
27. Hausdorff WP, Siber G, Paradiso PR. Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet 2001; 357: 950-952.
28. Lagos R, Munoz A, Valenzuela MT, Heitmann I, Levine MM. Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile. Pediatr Infect Dis J 2002; 21: 1115-1123.
29. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005; 5: 83-93.
30. Klein DL. Pneumococcal conjugate vaccines: Review and update. Microb Drug Resist 1995; 1: 49-58.
31. Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, Spratt BG. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis 2004; 190: 1203-1211.
32. Doit C, Loukil C, Geslin P, Bingen E. Phenotypic and genetic diversity of invasive pneumococcal isolates recovered from French children. J Clin Microbiol 2002; 40: 2994-2998.
33. Meats E, Brueggemann AB, Enright MC et al. Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae. J Clin Microbiol 2003; 41: 386-392.
34. Serrano I, Ramirez M, Melo-Cristino J, The Portuguese Surveillance Group for the Study of Respiratory Pathogens. Invasive Streptococcus pneumoniae from Portugal: Implications for vaccination and antimicrobial therapy. Clin Microbiol Infect 2004; 10: 652-656.
35. Soewignjo S, Gessner BD, Sutanto A et al. Streptococcus pneumoniae nasopharyngeal carriage prevalence, serotype distribution, and resistance patterns among children on Lombok Island, Indonesia. Clin Infect Dis 2001; 32: 1039-1043.
36. Rowe AK, Deming MS, Schwartz B et al. Antimicrobial resistance of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in the Central African Republic. Pediatr Infect Dis J 2000; 19: 438-444.
37. Frazao N, Brito-Avo A, Simas C et al. Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centers in Lisbon. Pediatr Infect Dis J 2005; 24: 243-252.
38. Moore MR, Hyde TB, Hennessy TW et al. Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. J Infect Dis 2004, 190: 2031-2038.